News and Announcements
PLMD Group intends to raise £1M after successfully raising £560K and achieving 45% unit growth rate
- Published September 02, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
PLMD Group is a full-service real estate investment firm on a mission to develop 1,000+ vibrant sustainable houses over the next seven years. The company strictly operates in the Build to Rent market, with over £20 million in assets under management.
PLMD Group’s market presence has grown rapidly thanks to their relationships with renowned institutions and private investors, a credible development portfolio, and a dedicated team that makes it all possible.
PLMD Group successfully raised £560,000 in two rounds of funding over the last year. Their investors haven’t had to wait long to see results as Dividend payments for the Becontree Avenue project were paid just last month. The company has grown from strength to strength in the last year, amassing over 85 units and is looking to expand even further. They are targeting a raise of £1 Million in the next 8-12 months through the use of Crowdfunding platforms and financial institutions.
PLMD Group intends to raise this capital by launching an income-generating product that will allow investors to invest passively in the exponentially growing Build to Rent market. This product provides investors with the ideal level of exposure to the BTR industry without the burden of full-time property management.
When asked about the raise, CEO Ajay Kapur expressed confidence in his team’s ability to meet the target, stating that this raise will contribute to their aim of adding £10 million in AUM by 2023. In such a fast-expanding industry, having the ambition and will to push forward and constantly grow is critical for success. PLMD Group is continually looking forward as a firm, and we seek like-minded individuals to join us on our growth path.
PLMD Group is excited to collaborate with investors who are interested in our story and all set to write their own!
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
